Let’s start up with the current stock price of Nemaura Medical Inc. (NMRD), which is $9.05 to be very precise. The Stock rose vividly during the last session to $9.625 after opening rate of $7.50 while the lowest price it went was recorded $7.50 before closing at $7.93.
Recently in News on May 6, 2021, Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany. Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced progress with the German regulatory authority (GBA) to achieve reimbursement for its sugarBEAT® device. You can read further details here
Nemaura Medical Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.54 on 05/06/21, with the lowest value was $3.71 for the same time period, recorded on 01/04/21.
Nemaura Medical Inc. (NMRD) full year performance was 79.21%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Nemaura Medical Inc. shares are logging -45.15% during the 52-week period from high price, and 190.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.12 and $16.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1530585 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Nemaura Medical Inc. (NMRD) recorded performance in the market was 140.05%, having the revenues showcasing -6.99% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 212.86M, as it employees total of 17 workers.
Specialists analysis on Nemaura Medical Inc. (NMRD)
During the last month, 0 analysts gave the Nemaura Medical Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.28, with a change in the price was noted +5.37. In a similar fashion, Nemaura Medical Inc. posted a movement of +145.92% for the period of last 100 days, recording 1,166,427 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NMRD is recording 0.51 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.17.
Trends and Technical analysis: Nemaura Medical Inc. (NMRD)
Raw Stochastic average of Nemaura Medical Inc. in the period of last 50 days is set at 40.78%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.78%. In the last 20 days, the company’s Stochastic %K was 35.89% and its Stochastic %D was recorded 41.81%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 140.05%. Additionally, trading for the stock in the period of the last six months notably improved by 146.59%, alongside a boost of 79.21% for the period of the last 12 months. The shares increased approximately by 92.55% in the 7-day charts and went up by 42.52% in the period of the last 30 days. Common stock shares were lifted by -6.99% during last recorded quarter.